Severe adverse systemic drug events occur commonly as a result of treatment of cancer
patients. Nephrotoxicity of chemotherapeutic agents remains a significant complication …

Platinum-based anticancer drugs (PADs), mainly cisplatin, carboplatin, and oxaliplatin, are
widely used efficacious long-standing anticancer agents for treating several cancer types …

The prevalence of CKD may be higher in patients with cancer than in those without due to
the addition of cancer-specific risk factors to those already present for CKD. In this review …

Onconephrology is a rapidly evolving subspeciality that covers all areas of renal
involvement in cancer patients. The complexity of the field may benefit from well-defined …

A precise and efficient method for estimating kidney function in cancer patients is important
to determine their eligibility for clinical trials and surgery and to allow for appropriate dose …

The development of formulas estimating glomerular filtration rate (eGFR) from serum
creatinine and cystatin C and accounting for certain variables affecting the production rate of …

Cancer patients are living longer. The sequelae of cancer treatment and the role of comorbid
conditions present before the diagnosis, such as CKD, have been increasingly recognized …

Background Burn patients often face a high risk of acute kidney injury (AKI) after severe burn
injuries, meanwhile epigallocatechin-3-gallate (EGCG) has been proven to be effective in …

Aim Accurate evaluation of glomerular filtration rate (GFR) is crucial in Oncology as drug
eligibility and dosing depend on estimates of GFR. However, there are no clear guidelines …

Mitochondrial transplantation (MT) is a new experimental approach that has demonstrated
positive results reverting mitochondrial alterations in cardiac and kidney dysfunction mainly …